{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:33:44Z","timestamp":1791516824736,"version":"4.3.4"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.canlet.2025.217514","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T10:44:32Z","timestamp":1738320272000},"page":"217514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Osalmid sensitizes clear cell renal cell carcinoma to navitoclax through a STAT3\/BCL-XL pathway"],"prefix":"10.1016","volume":"613","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3255-3150","authenticated-orcid":false,"given":"Yizheng","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanfeng","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Celeste","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6274-6404","authenticated-orcid":false,"given":"Wei","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.canlet.2025.217514_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur. Urol."},{"issue":"10","key":"10.1016\/j.canlet.2025.217514_bib2","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","article-title":"NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer","volume":"83","author":"Xie","year":"2023","journal-title":"Cancer Res."},{"issue":"32","key":"10.1016\/j.canlet.2025.217514_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302377","article-title":"A HER2-targeted antibody-drug conjugate, RC48-ADC, exerted promising antitumor efficacy and safety with intravesical instillation in preclinical models of bladder cancer","volume":"10","author":"Hong","year":"2023","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.canlet.2025.217514_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.eururo.2021.04.042","article-title":"The 2021 updated European association of urology guidelines on renal cell carcinoma: immune checkpoint inhibitor-based combination therapies for treatment-naive metastatic clear-cell renal cell carcinoma are standard of Care","volume":"80","author":"Bedke","year":"2021","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217514_bib5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1158\/2159-8290.CD-20-1638","article-title":"Overcoming resistance to tumor-targeted and immune-targeted therapies","volume":"11","author":"Aldea","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.217514_bib6","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","article-title":"Broad targeting of resistance to apoptosis in cancer","volume":"35","author":"Mohammad","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2025.217514_bib7","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.canlet.2025.217514_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216963","article-title":"Preoperative neoadjuvant targeted therapy remodels intra-tumoral heterogeneity of clear-cell renal cell carcinoma and ferroptosis inhibition induces resistance progression","volume":"593","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"issue":"7777","key":"10.1016\/j.canlet.2025.217514_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-019-1607-3","article-title":"Inducing and exploiting vulnerabilities for the treatment of liver cancer","volume":"574","author":"Wang","year":"2019","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.canlet.2025.217514_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","article-title":"Exploiting senescence for the treatment of cancer","volume":"22","author":"Wang","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.canlet.2025.217514_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.tcb.2018.04.006","article-title":"Two-step senescence-focused cancer therapies","volume":"28","author":"Sieben","year":"2018","journal-title":"Trends Cell Biol."},{"issue":"8","key":"10.1016\/j.canlet.2025.217514_bib12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cmet.2022.06.010","article-title":"GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment","volume":"34","author":"Missiaen","year":"2022","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib13","first-page":"131","article-title":"Blocking methionine catabolism induces senescence and confers vulnerability to GSK3 inhibition in liver cancer","volume":"5","author":"Li","year":"2024","journal-title":"Nat. Can. (Ott.)"},{"issue":"5","key":"10.1016\/j.canlet.2025.217514_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41416-018-0196-5","article-title":"MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1\/P-ERK axis","volume":"119","author":"Zhai","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.canlet.2025.217514_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12853","article-title":"The up-regulation of NDRG1 by HIF counteracts the cancer-promoting effect of HIF in VHL-deficient clear cell renal cell carcinoma","volume":"53","author":"Zhang","year":"2020","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12943-019-0998-y","article-title":"A positive feed-forward loop between LncRNA-URRCC and EGFL7\/P-AKT\/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma","volume":"18","author":"Zhai","year":"2019","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.canlet.2025.217514_bib17","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/ng.3984","article-title":"Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells","volume":"49","author":"Meyers","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2025.217514_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146961","article-title":"Screening and identification of CNIH4 gene associated with cell proliferation in gastric cancer based on a large-scale CRISPR-Cas9 screening database DepMap","volume":"850","author":"Zhang","year":"2023","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.canlet.2025.217514_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13338","article-title":"Cellular aging beyond cellular senescence: markers of senescence prior to cell cycle arrest in vitro and in vivo","volume":"20","author":"Ogrodnik","year":"2021","journal-title":"Aging Cell"},{"issue":"10","key":"10.1016\/j.canlet.2025.217514_bib20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/s43587-021-00121-8","article-title":"Strategies for targeting senescent cells in human disease","volume":"1","author":"Gasek","year":"2021","journal-title":"Nat Aging"},{"key":"10.1016\/j.canlet.2025.217514_bib21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.biochem.75.103004.142443","article-title":"Ribonucleotide reductases","volume":"75","author":"Nordlund","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.canlet.2025.217514_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bcp.2016.01.003","article-title":"Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein","volume":"103","author":"Liu","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217514_bib23","first-page":"443","article-title":"[Choleretic properties of oxaphenamide]","volume":"30","author":"Skakun","year":"1967","journal-title":"Farmakol. Toksikol. (Mosc.)"},{"issue":"4","key":"10.1016\/j.canlet.2025.217514_bib24","first-page":"446","article-title":"[Comparative study of action of dehydrocholic acid and oxaphenamide on bile secretion and cholate formation]","volume":"33","author":"Skakun","year":"1970","journal-title":"Farmakol. Toksikol. (Mosc.)"},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib25","first-page":"37","article-title":"[Effect of oxaphenamide on bile excretion and bile acid synthesis in experimental radiation sickness]","volume":"35","author":"Drogovoz","year":"1972","journal-title":"Farmakol. Toksikol. (Mosc.)"},{"issue":"5","key":"10.1016\/j.canlet.2025.217514_bib26","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/febs.16350","article-title":"Targeting cellular senescence with senotherapeutics: senolytics and senomorphics","volume":"290","author":"Zhang","year":"2023","journal-title":"FEBS J."},{"issue":"11","key":"10.1016\/j.canlet.2025.217514_bib27","first-page":"1284","article-title":"cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis","volume":"3","author":"Wang","year":"2022","journal-title":"Nat. Can. (Ott.)"},{"issue":"23\u201324","key":"10.1016\/j.canlet.2025.217514_bib28","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1101\/gad.343129.120","article-title":"Senescence and the SASP: many therapeutic avenues","volume":"34","author":"Birch","year":"2020","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.canlet.2025.217514_bib29","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-23-0821","article-title":"Bile acid metabolism mediates cholesterol homeostasis and promotes tumorigenesis in clear cell renal cell carcinoma","volume":"84","author":"Riscal","year":"2024","journal-title":"Cancer Res."},{"issue":"6444","key":"10.1016\/j.canlet.2025.217514_bib30","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217514_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217259","article-title":"Single-nucleus sequencing unveils heterogeneity in renal cell carcinomas microenvironment: insights into pathogenic origins and treatment-responsive cellular subgroups","volume":"604","author":"Zhang","year":"2024","journal-title":"Cancer Lett."},{"issue":"W1","key":"10.1016\/j.canlet.2025.217514_bib32","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.canlet.2025.217514_bib33","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1016\/j.ymthe.2021.05.020","article-title":"Hypoxia-induced lncHILAR promotes renal cancer metastasis via ceRNA for the miR-613\/206\/1-1-3p\/Jagged-1\/Notch\/CXCR4 signaling pathway","volume":"29","author":"Hu","year":"2021","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13046-019-1223-y","article-title":"The m(6)A-suppressed P2RX6 activation promotes renal cancer cells migration and invasion through ATP-induced Ca(2+) influx modulating ERK1\/2 phosphorylation and MMP9 signaling pathway","volume":"38","author":"Gong","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.canlet.2025.217514_bib35","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/ijc.30853","article-title":"DNA-methylation-mediated repression of miR-766-3p promotes cell proliferation via targeting SF2 expression in renal cell carcinoma","volume":"141","author":"Chen","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2025.217514_bib36","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.cell.2012.03.043","article-title":"Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair","volume":"149","author":"D'Angiolella","year":"2012","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.canlet.2025.217514_bib37","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.celrep.2013.03.004","article-title":"Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence","volume":"3","author":"Aird","year":"2013","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.canlet.2025.217514_bib38","first-page":"334","article-title":"Cytotoxic effects of auraptene against a human malignant glioblastoma cell line","volume":"9","author":"Afshari","year":"2019","journal-title":"Avicenna J Phytomed"},{"issue":"8","key":"10.1016\/j.canlet.2025.217514_bib39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","article-title":"Unmasking senescence: context-dependent effects of SASP in cancer","volume":"19","author":"Faget","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"14","key":"10.1016\/j.canlet.2025.217514_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm0756","article-title":"Early SRC activation skews cell fate from apoptosis to senescence","volume":"8","author":"Anerillas","year":"2022","journal-title":"Sci. Adv."},{"issue":"7686","key":"10.1016\/j.canlet.2025.217514_bib41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature25167","article-title":"Senescence-associated reprogramming promotes cancer stemness","volume":"553","author":"Milanovic","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217514_bib42","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1146\/annurev-pharmtox-050120-105018","article-title":"Senolytic drugs: reducing senescent cell viability to extend health span","volume":"61","author":"Robbins","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12964-017-0170-5","article-title":"The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling","volume":"15","author":"Toth","year":"2017","journal-title":"Cell Commun. Signal."},{"issue":"12","key":"10.1016\/j.canlet.2025.217514_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111826","article-title":"BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis","volume":"41","author":"Bharti","year":"2022","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.canlet.2025.217514_bib45","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1349-7006.2010.01552.x","article-title":"Bcl-XL and STAT3 mediate malignant actions of gamma-irradiation in lung cancer cells","volume":"101","author":"Ho","year":"2010","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.canlet.2025.217514_bib46","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s13402-023-00817-6","article-title":"Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cells","volume":"46","author":"Li","year":"2023","journal-title":"Cell. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2025.217514_bib47","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1158\/2159-8290.CD-14-1507","article-title":"HIF2alpha-Dependent lipid storage promotes endoplasmic reticulum homeostasis in clear-cell renal cell carcinoma","volume":"5","author":"Qiu","year":"2015","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.canlet.2025.217514_bib48","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1007\/s00259-024-06672-3","article-title":"ImmunoPET\/CT imaging of clear cell renal cell carcinoma with [(18)F]RCCB6: a first-in-human study","volume":"51","author":"Wu","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"7","key":"10.1016\/j.canlet.2025.217514_bib49","doi-asserted-by":"crossref","first-page":"e970","DOI":"10.1002\/ctm2.970","article-title":"Patient-derived renal cell carcinoma organoids for personalized cancer therapy","volume":"12","author":"Li","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"10","key":"10.1016\/j.canlet.2025.217514_bib50","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1021\/ac900166a","article-title":"Differential 12C-\/13C-isotope dansylation labeling and fast liquid chromatography\/mass spectrometry for absolute and relative quantification of the metabolome","volume":"81","author":"Guo","year":"2009","journal-title":"Anal. Chem."},{"issue":"12","key":"10.1016\/j.canlet.2025.217514_bib51","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1021\/acs.analchem.7b01098","article-title":"Development of high-performance chemical isotope labeling LC-MS for profiling the carbonyl submetabolome","volume":"89","author":"Zhao","year":"2017","journal-title":"Anal. Chem."},{"issue":"21","key":"10.1016\/j.canlet.2025.217514_bib52","doi-asserted-by":"crossref","first-page":"10617","DOI":"10.1021\/acs.analchem.6b02967","article-title":"Chemical isotope labeling LC-MS for high coverage and quantitative profiling of the hydroxyl submetabolome in metabolomics","volume":"88","author":"Zhao","year":"2016","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib53","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/s41467-019-09277-9","article-title":"A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis","volume":"10","author":"Zou","year":"2019","journal-title":"Nat. Commun."},{"issue":"10021","key":"10.1016\/j.canlet.2025.217514_bib54","first-page":"894","volume":"387","author":"Capitanio","year":"2016","journal-title":"Renal cancer. Lancet."},{"issue":"4","key":"10.1016\/j.canlet.2025.217514_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109441","article-title":"The Cancer SENESCopedia: a delineation of cancer cell senescence","volume":"36","author":"Jochems","year":"2021","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.canlet.2025.217514_bib56","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1158\/1541-7786.MCR-21-0146","article-title":"Identification of autophagy-related genes as targets for senescence induction using a customizable CRISPR-based suicide switch screen","volume":"19","author":"Schepers","year":"2021","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2025.217514_bib57","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.celrep.2017.09.085","article-title":"High-throughput functional genetic and compound screens identify targets for senescence induction in cancer","volume":"21","author":"Wang","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2025.217514_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216930","article-title":"LILRB2 inhibition enhances radiation sensitivity in non-small cell lung cancer by attenuating radiation-induced senescence","volume":"593","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217514_bib59","article-title":"Drug-induced senescence by aurora kinase inhibitors attenuates innate immune response of macrophages on gastric cancer organoids","volume":"598","author":"Yang","year":"2024","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.canlet.2025.217514_bib60","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.celrep.2015.04.014","article-title":"ATM couples replication stress and metabolic reprogramming during cellular senescence","volume":"11","author":"Aird","year":"2015","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.canlet.2025.217514_bib61","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.celrep.2019.07.084","article-title":"Suppression of p16 induces mTORC1-mediated nucleotide metabolic reprogramming","volume":"28","author":"Buj","year":"2019","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.canlet.2025.217514_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111396","article-title":"Targeting the USP7\/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC\/LSD1 inhibitors","volume":"40","author":"Granieri","year":"2022","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.canlet.2025.217514_bib63","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4161\/cc.26953","article-title":"Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer","volume":"13","author":"Aird","year":"2014","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13578-023-01157-6","article-title":"The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment","volume":"13","author":"Cheng","year":"2023","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib65","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1500106","article-title":"Predictors of disease aggressiveness influence outcome from immunotherapy treatment in renal clear cell carcinoma","volume":"8","author":"Kamal","year":"2019","journal-title":"OncoImmunology"},{"issue":"5","key":"10.1016\/j.canlet.2025.217514_bib66","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.ijrobp.2020.07.2322","article-title":"Osalmid, a novel identified RRM2 inhibitor, enhances radiosensitivity of esophageal cancer","volume":"108","author":"Tang","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2025.217514_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15165","article-title":"Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection","volume":"8","author":"Sinha","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12943-016-0565-8","article-title":"Choosing the right cell line for renal cell cancer research","volume":"15","author":"Brodaczewska","year":"2016","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2025.217514_bib69","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/1535-7163.MCT-19-0356","article-title":"Functional genomic screen in mesothelioma reveals that loss of function of BRCA1-associated protein 1 induces chemoresistance to ribonucleotide reductase inhibition","volume":"19","author":"Okonska","year":"2020","journal-title":"Mol. Cancer Therapeut."},{"issue":"12","key":"10.1016\/j.canlet.2025.217514_bib70","first-page":"5965","article-title":"RRM2 gene expression depends on BAF180 subunit of SWISNF chromatin remodeling complex and correlates with abundance of tumor infiltrating lymphocytes in ccRCC","volume":"11","author":"Szarkowska","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"5","key":"10.1016\/j.canlet.2025.217514_bib71","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ccell.2015.09.015","article-title":"Inhibiting WEE1 selectively kills histone H3K36me3-deficient cancers by dNTP starvation","volume":"28","author":"Pfister","year":"2015","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.canlet.2025.217514_bib72","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s42255-019-0122-z","article-title":"Cardiac glycosides are broad-spectrum senolytics","volume":"1","author":"Guerrero","year":"2019","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib73","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1038\/s41467-020-15719-6","article-title":"A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells","volume":"11","author":"Wakita","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.canlet.2025.217514_bib74","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","article-title":"ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor","volume":"68","author":"Tse","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib75","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41467-022-28741-7","article-title":"Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer","volume":"13","author":"Lopez","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib76","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1038\/s41467-018-05815-z","article-title":"Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity","volume":"9","author":"Soderquist","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217514_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11190","article-title":"Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL","volume":"7","author":"Yosef","year":"2016","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.canlet.2025.217514_bib78","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1158\/1078-0432.CCR-22-0669","article-title":"A mesenchymal tumor cell state confers increased dependency on the BCL-XL antiapoptotic protein in kidney cancer","volume":"28","author":"Grubb","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.canlet.2025.217514_bib79","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","article-title":"Senescence and cancer - role and therapeutic opportunities","volume":"19","author":"Schmitt","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib80","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2024.2420383","article-title":"GdX inhibits the occurrence and progression of breast cancer by negatively modulating the activity of STAT3","volume":"25","author":"Chen","year":"2024","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2025.217514_bib81","article-title":"H4K20me3-Mediated repression of inflammatory genes is a characteristic and targetable vulnerability of persister cancer cells","author":"Ramponi","year":"2024","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.canlet.2025.217514_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202100881","article-title":"RRM2 regulates sensitivity to sunitinib and PD-1 blockade in renal cancer by stabilizing ANXA1 and activating the AKT pathway","volume":"8","author":"Xiong","year":"2021","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.canlet.2025.217514_bib83","first-page":"1759","article-title":"Potential tumor-suppressive role of microRNA-99a-3p in sunitinib-resistant renal cell carcinoma cells through the regulation of RRM2","volume":"54","author":"Osako","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"21","key":"10.1016\/j.canlet.2025.217514_bib84","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.1158\/0008-5472.CAN-13-1094","article-title":"A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance","volume":"73","author":"Zhou","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217514_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103963","article-title":"Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach","volume":"78","author":"Li","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41392-020-0123-0","article-title":"A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2\/STAT3 pathway","volume":"5","author":"Lu","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2025.217514_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110556","article-title":"Identification of osalmid metabolic profile and active metabolites with anti-tumor activity in human hepatocellular carcinoma cells","volume":"130","author":"Wu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2025.217514_bib88","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2147\/OTT.S196347","article-title":"Ribonucleotide reductase subunit M2 as a novel target for clear-cell renal cell carcinoma","volume":"12","author":"Zou","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.canlet.2025.217514_bib89","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12943-021-01393-9","article-title":"Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma","volume":"20","author":"Ohmura","year":"2021","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2025.217514_bib90","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s13402-023-00819-4","article-title":"RRM2 as a novel prognostic and therapeutic target of NF1-associated MPNST","volume":"46","author":"Chung","year":"2023","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.canlet.2025.217514_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216993","article-title":"Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor","volume":"596","author":"Chow","year":"2024","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.canlet.2025.217514_bib92","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173934","article-title":"VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis","volume":"134","author":"Wolf","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.canlet.2025.217514_bib93","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008613","article-title":"Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study","volume":"12","author":"Wang","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"41","key":"10.1016\/j.canlet.2025.217514_bib94","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2408549121","article-title":"Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: initial experience and lessons learned","volume":"121","author":"Stransky","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T22:59:24Z","timestamp":1760741964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525000783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":94,"alternative-id":["S0304383525000783"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217514","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osalmid sensitizes clear cell renal cell carcinoma to navitoclax through a STAT3\/BCL-XL pathway","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217514"}}